Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 3917-3921, July 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dornish, J. M.
Right arrow Articles by Oftebro, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dornish, J. M.
Right arrow Articles by Oftebro, R.

Modifying Effect of Cinnamaldehyde and Cinnamaldehyde Derivatives on Cell Inactivation and Cellular Uptake of cis-Diamminedichloroplatinum(II) in Human NHIK 3025 Cells1

John M. Dornish2, Erik O. Pettersen and Reidar Oftebro

Department of Tissue Culture, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo 3, Norway

The effect of cinnamaldehyde and various cinnamaldehyde derivatives on cell inactivation induced by cis-diamminedichloroplatinum(II) (cis-DDP) was investigated using human NHIK 3025 cells in culture. Cell inactivation was measured as a loss in the ability of single cells to give rise to macroscopic colonies following drug treatment. It was found that cinnamaldehyde and {alpha}-chlorocinnamaldehyde potentiated the cell-inactivating effect when used simultaneously with cis-DDP without increasing the amount of cell-associated platinum. In contrast, a protective effect with respect to cell inactivation was found when cells were treated with cis-DDP in combination with hydrocinnamaldehyde or {alpha}-methylcinnamaldehyde. At higher concentrations (>1 mM) all cinnamaldehyde derivatives reduced cellular uptake of cis-DDP. Therefore, while protection from cis-DDP-induced cell inactivation involves reduced platinum uptake, potentiation by cinnamaldehyde and cinnamaldehyde derivatives does not seem to be due to an increase in intracellular platinum. We propose that cinnamaldehyde may compete with cis-DDP in nucleophilic addition reactions involving intracellular sulfhydryls.

1 This work was supported by grants from the Norwegian Cancer Society.

2 Fellow of the Norwegian Cancer Society. To whom requests for reprints should be addressed.

Received 9/ 7/88. Revised 2/24/89. Accepted 4/13/89.




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
J. Usta, S. Kreydiyyeh, P. Barnabe, Y. Bou-Moughlabay, and H. Nakkash-Chmaisse
Comparative study on the effect of cinnamon and clove extracts and their main components on different types of ATPases
Human and Experimental Toxicology, July 1, 2003; 22(7): 355 - 362.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
I. I. Budihardjo, S. A. Boerner, S. Eckdahl, P. A. Svingen, R. Rios, M. M. Ames, and S. H. Kaufmann
Effect of 6-Aminonicotinamide and Other Protein Synthesis Inhibitors on Formation of Platinum-DNA Adducts and Cisplatin Sensitivity
Mol. Pharmacol., March 1, 2000; 57(3): 529 - 538.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.